Matches in Wikidata for { <http://www.wikidata.org/entity/Q47201862> ?p ?o ?g. }
- Q47201862 description "2018 nî lūn-bûn" @default.
- Q47201862 description "2018 թվականի հունվարի 4-ին հրատարակված գիտական հոդված" @default.
- Q47201862 description "2018年の論文" @default.
- Q47201862 description "2018年学术文章" @default.
- Q47201862 description "2018年学术文章" @default.
- Q47201862 description "2018年学术文章" @default.
- Q47201862 description "2018年学术文章" @default.
- Q47201862 description "2018年学术文章" @default.
- Q47201862 description "2018年学术文章" @default.
- Q47201862 description "2018年學術文章" @default.
- Q47201862 description "2018年學術文章" @default.
- Q47201862 description "2018年學術文章" @default.
- Q47201862 description "2018年學術文章" @default.
- Q47201862 description "2018年學術文章" @default.
- Q47201862 description "2018년 논문" @default.
- Q47201862 description "article científic" @default.
- Q47201862 description "article scientific" @default.
- Q47201862 description "article scientifique" @default.
- Q47201862 description "articol științific" @default.
- Q47201862 description "articolo scientifico" @default.
- Q47201862 description "artigo científico" @default.
- Q47201862 description "artigo científico" @default.
- Q47201862 description "artigo científico" @default.
- Q47201862 description "artikel ilmiah" @default.
- Q47201862 description "artikull shkencor" @default.
- Q47201862 description "artikulong pang-agham" @default.
- Q47201862 description "artykuł naukowy" @default.
- Q47201862 description "artículo científico publicado en 2018" @default.
- Q47201862 description "artículu científicu" @default.
- Q47201862 description "bilimsel makale" @default.
- Q47201862 description "bài báo khoa học" @default.
- Q47201862 description "naučni članak" @default.
- Q47201862 description "scienca artikolo" @default.
- Q47201862 description "scientific article published on 4 January 2018" @default.
- Q47201862 description "scientific article published on 4 January 2018" @default.
- Q47201862 description "scientific article published on 4 January 2018" @default.
- Q47201862 description "teaduslik artikkel" @default.
- Q47201862 description "tieteellinen artikkeli" @default.
- Q47201862 description "tudományos cikk" @default.
- Q47201862 description "vedecký článok" @default.
- Q47201862 description "vetenskaplig artikel" @default.
- Q47201862 description "videnskabelig artikel" @default.
- Q47201862 description "vitenskapelig artikkel" @default.
- Q47201862 description "vitskapeleg artikkel" @default.
- Q47201862 description "vědecký článek" @default.
- Q47201862 description "wetenschappelijk artikel" @default.
- Q47201862 description "wissenschaftlicher Artikel" @default.
- Q47201862 description "επιστημονικό άρθρο" @default.
- Q47201862 description "мақолаи илмӣ" @default.
- Q47201862 description "наукова стаття, опублікована в січні 2018" @default.
- Q47201862 description "научна статия" @default.
- Q47201862 description "научная статья" @default.
- Q47201862 description "научни чланак" @default.
- Q47201862 description "научни чланак" @default.
- Q47201862 description "מאמר מדעי" @default.
- Q47201862 description "مقالة علمية نشرت في 4 يناير 2018" @default.
- Q47201862 description "৪ জানুয়ারি ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q47201862 description "บทความทางวิทยาศาสตร์" @default.
- Q47201862 description "სამეცნიერო სტატია" @default.
- Q47201862 name "Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1." @default.
- Q47201862 name "Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1." @default.
- Q47201862 type Item @default.
- Q47201862 label "Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1." @default.
- Q47201862 label "Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1." @default.
- Q47201862 prefLabel "Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1." @default.
- Q47201862 prefLabel "Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1." @default.
- Q47201862 P1433 Q47201862-56743982-E3D2-4DA1-805B-29C5CD8C5D18 @default.
- Q47201862 P1476 Q47201862-E341672C-C65B-4577-9D7A-0A279454D137 @default.
- Q47201862 P2093 Q47201862-035635DA-E68B-4FD8-8F6E-997C78D907EE @default.
- Q47201862 P2093 Q47201862-076E470F-4349-474A-88BA-44CBAE4ADECC @default.
- Q47201862 P2093 Q47201862-198DF338-AE01-45CD-BD7C-E046DADBEC17 @default.
- Q47201862 P2093 Q47201862-2044A0EF-EA88-4382-B216-D030AD0137EF @default.
- Q47201862 P2093 Q47201862-207D880F-B7B9-4FF6-887F-D17E74EB1B4F @default.
- Q47201862 P2093 Q47201862-2B39DC62-6129-4CDF-B2B9-2EA3B6619DEF @default.
- Q47201862 P2093 Q47201862-3124D04F-3DB3-48AF-8230-091DDC15F101 @default.
- Q47201862 P2093 Q47201862-50D3A985-F344-417B-9AC2-466721FDF928 @default.
- Q47201862 P2093 Q47201862-5BCE8B00-5D54-438E-9713-6E01656F5501 @default.
- Q47201862 P2093 Q47201862-619C07AC-8FFA-4B0B-A097-717E074A392C @default.
- Q47201862 P2093 Q47201862-67246B2C-2534-465C-80F9-B5C1A808B9D0 @default.
- Q47201862 P2093 Q47201862-70FF28D8-4C8C-4E18-9939-9C6B4ECA601E @default.
- Q47201862 P2093 Q47201862-AAC436C2-BCA6-45FB-8BB3-32E8B989FE0D @default.
- Q47201862 P2093 Q47201862-B4625E80-90A0-4A50-B7ED-988276C86576 @default.
- Q47201862 P2093 Q47201862-CCFABF40-1F59-4093-90B8-C7F9E88FD9BC @default.
- Q47201862 P2093 Q47201862-CF52FEC3-0DE2-4FA9-9472-C4B9BFF1B41A @default.
- Q47201862 P2093 Q47201862-ECB299B0-B5C8-4A6F-9147-9D27F4262C26 @default.
- Q47201862 P2093 Q47201862-ED994F28-C92F-4E33-A4DD-644CC224E803 @default.
- Q47201862 P304 Q47201862-021E4D6D-B06E-4119-95A2-61435C55EEF6 @default.
- Q47201862 P31 Q47201862-C0420696-3C95-4125-A762-5640B7D35959 @default.
- Q47201862 P356 Q47201862-168251E2-9D2F-4B5C-A611-E46CBA02BE7A @default.
- Q47201862 P478 Q47201862-1F0B9C08-A6E2-412A-A9D1-8A347B783EFF @default.
- Q47201862 P577 Q47201862-DD978B76-2A30-40AC-A5AB-E43B5C8F0667 @default.
- Q47201862 P698 Q47201862-B125DAC6-28CB-4D55-83F3-B47B6A645BE4 @default.
- Q47201862 P921 Q47201862-2E149DCC-187F-45A4-AA4C-DD015F2DA3C8 @default.
- Q47201862 P921 Q47201862-FDA218A2-AD26-4428-95FD-149244F699C0 @default.
- Q47201862 P356 J.EJCA.2017.12.001 @default.
- Q47201862 P698 29306769 @default.
- Q47201862 P1433 Q332260 @default.
- Q47201862 P1476 "Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1." @default.
- Q47201862 P2093 "A Enk" @default.
- Q47201862 P2093 "A Freitag" @default.